Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org
SOURCE Research and Markets
DUBLIN, October 4, 2017 /PRNewswire/ --
The "FDA's Medical Device Software Regulation Strategy: 2-Day In-Person Seminar by Ex-FDA Official" conference has been added to Research and Markets' offering.
The growth of the medical software industry outpaces the design of FDA's regulatory process. In some instances clinicians have weighed the risk of software failure against the benefits of using a device at all. Device software is often used in conjunction with other software-based devices, but their interoperability was never anticipated.
This seminar will focus on addressing these concerns and educating participants on FDA's recent medical device software regulation strategies.
Medical device trade and healthcare professionals remain plagued by other issues, such as the interoperability of devices from different manufacturers, or software validation that is limited to the immediate use of the software rather than its performance with other software programs, and software hacking protection applications. In case of software malfunction, fixing the malfunction or bug can get more difficult as software gets increasingly sophisticated, customized by users and placed in a network system. Under these circumstances, it is difficult to decide who is responsible for managing and fixing software problems.
This seminar will help those involved in overcoming these commercial and regulatory obstacles. It will highlight the need for firms to remain current with technological tools and strategy to remain competitive, and ideally, outside FDA's regulatory radar. Going further, it will instruct participants on how to apply these tools and strategies to ensure the following factors:
For those who have addressed these issues to meet FDA's regulatory expectations, the course instructor, a former FDA official, will help identify a basic centering point to build a regulatory profile for your software products.
FDA's risk classification will gradually clarify how it intends to manage the health risks. Risk factors include areas such as the following:
Software problems represent one of the most common root causes for recalls and have been associated with deaths and serious injuries as well. FDA sees firms revise software only to have it create more problems rather than solve them. The infusion pump industry is a classic example.
Who Will Benefit:
For more information about this conference visit https://www.researchandmarkets.com/research/xb3rfq/fdas_medical
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/2-day-in-person-seminar-by-ex-fda-official-fdas-medical-device-software-regulation-strategy-san-diego-ca-united-states---november-16-17-2017-300530810.html
©2017 PR Newswire. All Rights Reserved.